Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management

被引:86
作者
Chen, S. C. A. [1 ]
Marriott, D. [2 ]
Playford, E. G. [3 ]
Nguyen, Q. [2 ]
Ellis, D. [4 ]
Meyer, W. [1 ,5 ]
Sorrell, T. C. [1 ]
Slavin, M. [6 ]
机构
[1] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead, NSW 2145, Australia
[2] St Vincents Hosp, Dept Microbiol, Sydney, NSW 2010, Australia
[3] Princess Alexandra Hosp, Infect Management Serv, Brisbane, Qld 4102, Australia
[4] Womens & Childrens Hosp, Mycol Unit, Adelaide, SA, Australia
[5] Westmead Hosp, Mol Mycol Res Lab, Sydney, NSW, Australia
[6] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia
关键词
antifungal susceptibility; candidaemia; outcome; risk factors; uncommon Candida species; IN-VITRO SUSCEPTIBILITIES; ACTIVE SURVEILLANCE; UNITED-STATES; RISK-FACTORS; EPIDEMIOLOGY; DUBLINIENSIS; FUNGEMIA; ALBICANS; IDENTIFICATION; INFECTIONS;
D O I
10.1111/j.1469-0691.2009.02821.x
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
P>The risk factors for and clinical features of bloodstream infection with uncommon Candida spp. (species other than C. albicans, C. glabrata, C. parapsilosis, C. tropicals and C. krusei) are incompletely defined. To identify clinical variables associated with these species that might guide management, 57 cases of candidaemia resulting from uncommon Candida spp. were analysed in comparison with 517 episodes of Candida albicans candidaemia (2001-2004). Infection with uncommon Candida spp. (5.3% of candidaemia cases), as compared with C. albicans candidaemia, was significantly more likely to be outpatient-acquired than inpatient-acquired (15 of 57 vs. 65 of 517 episodes, p 0.01). Prior exposure to fluconazole was uncommon (n = 1). Candida dubliniensis was the commonest species (n = 22, 39%), followed by Candida guilliermondii (n = 11, 19%) and Candida lusitaniae (n = 7, 12%).C. dubliniensis candidaemia was independently associated with recent intravenous drug use (p 0.01) and chronic liver disease (p 0.03), and infection with species other than C. dubliniensis was independently associated with age < 65 years (p 0.02), male sex (p 0.03) and human immunodeficiency virus infection (p 0.05). Presence of sepsis at diagnosis and crude 30-day mortality rates were similar for C. dubliniensis-related, non-C. dubliniensis-related and C. albicans-related candidaemia. Haematological malignancy was the commonest predisposing factor in C. guilliermondii (n = 3, 27%) and C. lusitaniae (n = 3, 43%) candidaemia. The 30-day mortality rate of C. lusitaniae candidaemia was higher than the overall death rate for all uncommon Candida spp. (42.9% vs. 25%, p not significant). All isolates were susceptible to amphotericin B, voriconazole, posaconazole, and caspofungin; five strains (9%) had fluconazole MIC values of 16-32 mg/L. Candidaemia due to uncommon Candida spp. is emerging among hospital outpatients; certain clinical variables may assist in recognition of this entity.
引用
收藏
页码:662 / 669
页数:8
相关论文
共 36 条
[1]
Candida lusitaniae fungemia in cancer patients:: risk factors for amphotericin B failure and outcome [J].
Atkinson, Bradley J. ;
Lewis, Russell E. ;
Kontoyiannis, Dimitrios P. .
MEDICAL MYCOLOGY, 2008, 46 (06) :541-546
[2]
*AUSTR GOV DEP HLT, 2004, INF CONTR GUID PREV
[3]
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer [J].
Bodey, GP ;
Mardani, M ;
Hanna, HA ;
Boktour, M ;
Abbas, J ;
Girgawy, E ;
Hachem, RY ;
Kontoyiannis, DP ;
Raad, II .
AMERICAN JOURNAL OF MEDICINE, 2002, 112 (05) :380-385
[4]
Adherence of different Candida dubliniensis isolates in the presence of fluconazole [J].
Borg-von Zepelin, M ;
Niederhaus, T ;
Gross, U ;
Seibold, M ;
Monod, M ;
Tintelnot, K .
AIDS, 2002, 16 (09) :1237-1244
[5]
Active surveillance for candidemia, Australia [J].
Chen, Sharon ;
Slavin, Monica ;
Nguyen, Quoc ;
Marriott, Deborah ;
Playford, E. Geoffrey ;
Ellis, David ;
Sorrell, Tania .
EMERGING INFECTIOUS DISEASES, 2006, 12 (10) :1508-1516
[6]
Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit [J].
Chow, Jennifer K. ;
Golan, Yoav ;
Ruthazer, Robin ;
Karchmer, Adolf W. ;
Carmeli, Yehuda ;
Lichtenberg, Deborah ;
Chawla, Varun ;
Young, Janet ;
Hadley, Susan .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) :1206-1213
[7]
*CLIN LAB STAND I, 2002, REF METH BROTH DIL A, V22, P15
[8]
Outbreak of Candida rugosa candidemia:: an emerging pathogen that may be refractory to amphotericin B therapy [J].
Colombo, AL ;
Melo, ASA ;
Rosas, RFC ;
Salomao, R ;
Briones, MRS ;
Hollis, RJ ;
Messer, SA ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (04) :253-257
[9]
Prospective observational study of candidemia in Sao Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality [J].
Colombo, Arnaldo L. ;
Guimaraes, Thais ;
Silva, Ligia R. B. F. ;
Monfardini, Leila Paula de Almeida ;
Cunha, Anna Karenine B. ;
Rady, Patricia ;
Alves, Thelma ;
Rosas, Robert C. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (05) :570-576
[10]
Epidemiology of candidemia in Brazil:: a nationwide sentinel surveillance of candidemia in eleven medical Centers [J].
Colombo, Arnaldo L. ;
Nucci, Marcio ;
Park, Benjamin J. ;
Nouer, Simone A. ;
Arthington-Skaggs, Beth ;
da Matta, Daniel A. ;
Warnock, David ;
Morgan, Juliette .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2816-2823